Green Light to Launch: The Definitive Step-by-Step FTO Analysis Guide for New Drug Products
How to conduct a freedom-to-operate analysis that holds up in court, survives investor due diligence, and actually protects your pipeline […]
Value a Biotech Like a Pro: The Metrics That Actually Move Price Targets
An Investigative Analysis of Pharmaceutical and Biotech Valuation Frameworks Why Most Biotech Valuations Get It Wrong Every quarter, analysts revise
Value a Biotech Like a Pro: The Metrics That Actually Move Price Targets Read Post »
Patent vs. Regulatory Exclusivity: The Drug Industry’s Two-Layer Protection System Explained
What You Actually Need to Know About the Dual Shield Most people conflate drug patents with drug exclusivity. They are
First to File. First to Profit: The Complete Guide to Paragraph IV Certifications and 180-Day Exclusivity
How generic drug companies legally exploit the Hatch-Waxman framework to generate billion-dollar windfalls — and how brand manufacturers fight back
20 Years on Paper: The Real Guide to Drug Patent Duration in the United States
The Patent Clock Nobody Shows You The standard answer to “how long does a patent last?” is 20 years. You
20 Years on Paper: The Real Guide to Drug Patent Duration in the United States Read Post »
When to Switch: Using Loss-of-Exclusivity Data to Time Generic and Biosimilar Formulary Substitutions
How payers, PBMs, and formulary committees can convert LOE intelligence into measurable cost savings — and why most of them
Read Their Drug Pipeline Before They Publish It: Competitive Forecasting with Pharmaceutical Patent Intelligence
A Practical Guide to Tracking Competitors’ R&D Pipelines Before They Make Headlines The Intelligence Gap That Costs Billions Every pharmaceutical
Pick the Right Patent Or Leave Billions on the Table: The Definitive Guide to the One-Patent-Per-Product Rule and PTE Selection Strategy
The Decision That Defines Decades of Revenue Somewhere between the FDA approval notice hitting a pharmaceutical company’s inbox and the
South American Drug Patents: The Definitive Country-by-Country Breakdown
Patent Terms, Data Exclusivity, Compulsory Licensing, and Generic Entry Across 11 Markets Why South America Is the World’s Most Contested
South American Drug Patents: The Definitive Country-by-Country Breakdown Read Post »
